FPS Economy Belgium September: Export Recovery Led by Pharma and Logistics as Domestic Industry Stabilises
Belgium's Federal Public Service Economy September statistics show export recovery beginning — particularly in pharmaceuticals and logistics — while domestic industrial production gradually recovers from the Antwerp chemical cluster shock.
According to Belgium's Federal Public Service Economy (FPS Economy, September 2026), Belgium's goods exports are showing signs of recovery in Q3 2026, led by the pharmaceutical sector and the logistics and transport services sector, while domestic industrial production has stabilised above the Q2 2026 lows that followed the most acute phase of the energy shock. The FPS Economy data for September provides the most current official Belgian economic statistics available, covering trade, industrial production, and employment trends across the Belgian economy.
Belgium's pharmaceutical export performance has remained strong through Q3 2026, with US tariff exemptions on pharmaceutical shipments providing a reliable commercial foundation for the sector's export activities. Belgium is one of the EU's most important pharmaceutical manufacturing bases — hosting facilities for UCB, Janssen (J&J), AstraZeneca, and numerous other multinational and generic drug manufacturers — and the sector's continued strong performance provides both direct GDP contribution and significant indirect demand through the supply chain for packaging, transport, and professional services.
Logistics and transport services have recovered more quickly than manufacturing in Belgium's Q3 2026 economic data. Belgium's position as a European logistics hub — centred on the Port of Antwerp, which handles approximately 12% of all European container traffic — means that as European trade flows gradually recover from the H1 2026 suppression caused by the energy shock and geopolitical uncertainty, Belgian logistics operators are among the first beneficiaries. Container throughput at Antwerp has recovered toward normal seasonal levels in Q3 2026 as European import and export demand gradually improves.
Industrial production across Belgium's non-pharmaceutical manufacturing segments has stabilised in Q3 2026, after the sharp capacity utilisation decline that characterised the Antwerp petrochemical cluster in Q2. The stabilisation reflects the moderation of European natural gas prices through the summer, which has improved the economics of basic chemical production sufficiently to allow some previously curtailed production lines to resume. The pace of production recovery remains gradual, however, as producers are cautious about recommitting to full capacity until the trajectory of energy prices is more clearly established.
Belgium's labour market has shown greater resilience than the GDP data alone might suggest. The approximately 90,000 new jobs projected for 2026-2028 by the NBB's June projections remain broadly on track, with services and healthcare employment continuing to grow. Manufacturing employment has been more cautious, with firms maintaining their workforces through the shock period using short-time working and temporary contract reductions rather than permanent redundancies — a Belgian labour market flexibility mechanism that has historically limited the extent of recession-induced unemployment increases.
